Check out our most recent publication in Molecular Pharmacology!

In this article, we share how we can use our human taste bud tissue-derived cell (hTBEC) cultures to identify small molecules to suppress bitterness associated with a commonly used anti-HIV drug. This finding may be particularly helpful for pediatric and geriatric populations where compliance with an oral medicine because of bitter taste is a significant problem. This work was conducted by the combined efforts of DiscoveryBioMed’s new sensory cell sector Sentirix, the Monell Chemical Senses Center, a world leader in taste and smell research, and the Rutgers University Department of Nutritional Sciences. Read more in the link here!

Return to News